The utility of next generation sequencing-based minimal residual disease monitoring in a post-myeloproliferative neoplasm acute myeloid leukemia patient: a case report

被引：0

作者：

Choi, Yu Jeong ^{[1
]}

Kook, Hye Won ^{[2
]}

Lee, Seung-Tae ^{[1
,3
]}

Song, Jaewoo ^{[1
]}

Choi, Jong Rak ^{[1
,3
]}

Cheong, June-Won ^{[2
]}

Shin, Saeam ^{[1
]}

机构：

[1] Yonsei Univ, Severance Hosp, Dept Lab Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea

[2] Yonsei Univ, Coll Med, Div Hematol, Severance Hosp,Dept Internal Med, 50 Yonsei Ro, Seoul 03722, South Korea

[3] Dxome co Ltd, Seongnam, South Korea

来源：

LEUKEMIA & LYMPHOMA | 2024年 / 65卷 / 13期

基金：

新加坡国家研究基金会;

关键词：

POLYCYTHEMIA-VERA; PROGNOSIS;

D O I：

10.1080/10428194.2024.2385498

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2040 / 2043

页数：4

共 50 条

[1] Next generation sequencing-based monitoring for minimal residual disease in acute myeloid leukemia
Ok, Chi Young
Salim, Alaa
Luthra, Rajyalakshmi
Patel, Keyur
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S196 - S196
[2] Clinical Utility of Next-Generation Sequencing-Based Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia
Sekiya, Yuko
Okuno, Yusuke
Muramatsu, Hideki
Narita, Atsushi
Suzuki, Kyogo
Wang, Xinan
Kawashima, Nozomu
Xu, Yinyan
Sakaguchi, Hirotoshi
Yoshida, Nao
Hama, Asahito
Takahashi, Yoshiyuki
Kato, Koji
Kojima, Seiji
BLOOD, 2015, 126 (23)
[3] NEXT GENERATION SEQUENCING TARGETED PANEL FOR MINIMAL RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA
Mcclain, V.
Carson, A. R.
Patay, B. A.
Chamberlain, L.
Chander, C.
Zheng, S.
Huang, W.
Kiya, O.
Hubbard, D.
Caguioa, D.
Xie, Z.
Thornes, J.
Stenzel, T.
Miller, J. E.
HAEMATOLOGICA, 2017, 102 : 45 - 46
[4] Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
Mai, Huirong
Li, Qin
Wang, Guobing
Wang, Ying
Liu, Shilin
Tang, Xue
Chen, Fen
Zhou, Guichi
Liu, Yi
Li, Tonghui
Wang, Lulu
Wang, Chunyan
Wen, Feiqiu
Liu, Sixi
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3259 - 3266
[5] Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemia
Huirong Mai
Qin Li
Guobing Wang
Ying Wang
Shilin Liu
Xue Tang
Fen Chen
Guichi Zhou
Yi Liu
Tonghui Li
Lulu Wang
Chunyan Wang
Feiqiu Wen
Sixi Liu
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 3259 - 3266
[6] Next generation sequencing based approach for monitoring of minimal residual disease in acute lymphoblastic leukemia
Komkov, A.
Minervina, A.
Pogorelyy, M.
Zvyagin, I.
Panferova, A.
Olshanskaya, Y.
Chudakov, D.
Maschan, M.
Mamedov, I.
Lebedev, Y.
FEBS JOURNAL, 2016, 283 : 376 - 376
[7] Patient-Tailored Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Next Generation Sequencing
Malmberg, Erik
Stahlman, Sara
Rehammar, Anna
Samuelsson, Tore
Alm, Sofie J.
Kristiansson, Erik
Abrahamsson, Jonas
Garelius, Hege
Palmqvist, Lars
Fogelstrand, Linda
BLOOD, 2015, 126 (23)
[8] Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
Levine, Ross L.
Valk, Peter J. M.
HAEMATOLOGICA, 2019, 104 (05) : 868 - 871
[9] Next-generation sequencing-based minimal residual disease monitoring in patients receiving allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia or myelodysplastic syndrome
Shapiro, Roman M.
Kim, Dennis Dong Hwan
CURRENT OPINION IN HEMATOLOGY, 2018, 25 (06) : 425 - 432
[10] Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing
Malmberg, Erik B. R.
Stahlman, Sara
Rehammar, Anna
Samuelsson, Tore
Alm, Sofie J.
Kristiansson, Erik
Abrahamsson, Jonas
Garelius, Hege
Pettersson, Louise
Ehinger, Mats
Palmqvist, Lars
Fogelstrand, Linda
EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (01) : 26 - 37

← 1 2 3 4 5 →